According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of Yaz and Yasmin lawsuits, Bayer has set these funds aside, as it faces thousands more lawsuits.
Bayer recently reached a settlement agreement of $1 billion in 4,800 lawsuits filed against them in the U.S. These nearly 5,000 lawsuits were filed against the German pharmaceutical company because, as the plaintiffs claim, ingestion of the contraceptives Yaz and Yasmin resulted in the formation of blood clots causing heart attack, stroke, and even death.
Though Bayer has settled these 4,800 Yaz and Yasmin lawsuits, they still face over 11,000 more in the U.S. alone. In Canada, the manufacturer of Yaz and Yasmin will be up against 13 class action lawsuits.
A Yaz multi-district litigation (MDL) has been established in a U.S. District Court for the Southern District of Illinois. Yaz and Yasmin lawsuits have been consolidated into the MDL, which is known as In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation MDL 2100. The Yaz MDL 2100 is being overheard by Judge David Herndon, who in 2011 postponed bellwether trials.
Lawyers at Carey Danis & Lowe have been following the Yaz and Yasmin MDL in order to determine if the MDL proceedings will be affected at all by any recent Yaz and Yasmin settlements or other actions made by Bayer, such as their most recent public move in allocating over $1 billion for legal expenses.
Women who have filed Yaz and Yasmin lawsuits have experienced serious health complications, some of which have been fatal. Plaintiffs in these lawsuits allege that Bayer, in addition to releasing a defective, harmful drug onto the market, are also guilty of withholding information about the health risks of using these two contraceptive drugs along with employing deceptive marketing practices.
Lawyers at Carey Danis & Lowe encourage women who have been injured by Yaz or Yasmin to contact an experienced trial lawyer at Carey Danis & Lowe today for a free legal evaluation about a Yaz and Yasmin case. As Bayer’s most recent fund transfer demonstrates, they are preparing to settle these lawsuits as opposed to fighting them.